-
Symbol
-
XFOR on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
2.44M shares
-
Security Ownership
-
9.99%
Bain Capital Life Sciences Fund, L.P. ownership in X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR)
2025-09-15 - Bain Capital Life Sciences Fund, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.44M shares of X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR).
This represents 9.99% percent ownership of the company.
In their previous filing dated 2025-08-13, Bain Capital Life Sciences Fund, L.P. had reported owning 2.44M shares, indicating an increase of 0% percent.